ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Merck KGaA 

Frankfurter Street 250

Darmstadt    D-64293  Germany
Phone: 49-6151-720 Fax: 49-6151-722000


SEARCH JOBS


Industry
Biotechnology


Collaborations

SmithKline Beecham 

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in diabetes and obesity.

GlaxoSmithKline (North Carolina) 

TargeGen, Inc.  Licensing Agreement - Vascular Biology Portfolio.





 Company News
Oncothyreon Inc. (ONTY) Announces Merck KGaA (MKGAF.PK), Darmstadt, Germany, Initiation Of Phase 3 Start2 Study With Tecemotide In Stage III Non-Small Cell Lung Cancer 4/7/2014 9:35:30 AM    More...
Merck KGaA (MKGAF.PK) Loses R&D Chief, Head Of Merck Millipore In Senior Reshuffle 3/28/2014 7:26:41 AM    More...
Threshold Pharmaceuticals, Inc. (THLD)' Partner Merck KGaA (MKGAF.PK), Darmstadt, Germany Initiates Phase 1 Dose Escalation Study Of TH-302 In Combination With Gemcitabine And Nab-paclitaxel (Abraxane(R)) In Pancreatic Cancer 3/27/2014 11:12:00 AM    More...
Merck KGaA (MKGAF.PK)'s Profit Up As Cutbacks Cancel Out Forex Pain 3/6/2014 7:17:23 AM    More...
Merck KGaA (MKGAF.PK) Has Cash Ready To Pursue A Takeover Worth Billions: CEO 2/21/2014 7:28:11 AM    More...
Merck KGaA (MKGAF.PK) Shaken Due To CFO's Surprise Exit 1/28/2014 8:07:06 AM    More...
Pharmaceutical Unit Integral To Growth Strategy: Merck KGaA (MKGAF.PK) 1/22/2014 9:25:40 AM    More...
Merck KGaA (MKGAF.PK) Tests Ground For Iran Partnership To Produce Medicines 12/30/2013 7:43:05 AM    More...
EU Approves Merck KGaA (MKGAF.PK)'s Erbitux For A Subtype Of Cancer 12/23/2013 7:21:16 AM    More...
Germany's Merck KGaA (MKGAF.PK) Dips Into Hi-Tech Materials With $2.6 Billion Buy 12/5/2013 6:52:53 AM    More...
12345678910...